Alvotech (ALVO) Earnings Date & Reports

Alvotech is an integrated biopharmaceutical company committed to developing and manufacturing high-quality biosimilar medicines for patients globally... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

ALVO is expected to report earnings to fall 109.66% to -3 cents per share on August 13

Q2'25

Est.

$-0.03

Q1'25

Beat

by $0.32

Q4'24

Missed

by $0.15

Q3'24

Beat

by $0.03

Q2'24

Missed

by $0.59

The last earnings report on May 07 showed earnings per share of 34 cents, beating the estimate of 2 cents. With 154.46K shares outstanding, the current market capitalization sits at 3.48B.

View a ticker or compare two or three

Compare

ALVO